IK
Gene Information
- Official Symbol: IK
- Official Name: IK cytokine
- Aliases and Previous Symbols: N/A
- Entrez ID: 3550
- UniProt: Q13123
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Auxiliary spliceosomal protein that regulates selection of alternative splice sites in a small set of target pre-mRNA species (Probable). Required for normal mitotic cell cycle progression (PubMed:22351768, PubMed:24252166). Recruits MAD1L1 and MAD2L1 to kinetochores, and is required to trigger the spindle assembly checkpoint (PubMed:22351768). Required for normal accumulation of SMU1 (PubMed:24945353). {ECO:0000269|PubMed:22351768, ECO:0000269|PubMed:24252166, ECO:0000269|PubMed:24945353, ECO:0000305}.
Pfam Domains GO Terms
Pfam Domains
| RED C |
| RED N |
GO Terms
| protein localization to kinetochore |
| protein localization to chromosome, centromeric region |
| mitotic spindle assembly checkpoint |
| spindle checkpoint |
| mitotic spindle checkpoint |
| spindle assembly checkpoint |
| negative regulation of mitotic metaphase/anaphase transition |
| negative regulation of metaphase/anaphase transition of cell cycle |
| mitotic spindle pole |
| negative regulation of mitotic sister chromatid separation |
| negative regulation of chromosome separation |
| nuclear chromosome |
| negative regulation of mitotic sister chromatid segregation |
| negative regulation of sister chromatid segregation |
| negative regulation of chromosome segregation |
| negative regulation of mitotic nuclear division |
| negative regulation of nuclear division |
| U2-type precatalytic spliceosome |
| regulation of mitotic metaphase/anaphase transition |
| regulation of metaphase/anaphase transition of cell cycle |
| regulation of mitotic sister chromatid separation |
| regulation of chromosome separation |
| protein localization to chromosome |
| regulation of mitotic sister chromatid segregation |
| regulation of sister chromatid segregation |
| regulation of chromosome segregation |
| negative regulation of chromosome organization |
| mitotic cell cycle checkpoint |
| regulation of mitotic nuclear division |
| regulation of nuclear division |
| cell cycle checkpoint |
| negative regulation of mitotic cell cycle phase transition |
| negative regulation of cell cycle phase transition |
| mRNA splicing, via spliceosome |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
| RNA splicing, via transesterification reactions |
| negative regulation of mitotic cell cycle |
| negative regulation of cell cycle process |
| regulation of chromosome organization |
| negative regulation of organelle organization |
| RNA splicing |
| nuclear speck |
| regulation of mitotic cell cycle phase transition |
| regulation of cell cycle phase transition |
| mRNA processing |
| negative regulation of cell cycle |
| mitotic cell cycle process |
| regulation of mitotic cell cycle |
| mitotic cell cycle |
| mRNA metabolic process |
| viral process |
| negative regulation of cellular component organization |
| protein localization to organelle |
| regulation of cell cycle process |
| symbiotic process |
| interspecies interaction between organisms |
| RNA processing |
| cell cycle process |
| identical protein binding |
| regulation of cell cycle |
| regulation of organelle organization |
| cell cycle |
| cellular protein localization |
| cellular macromolecule localization |
| RNA metabolic process |
| gene expression |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| Etoposide 1μM R00 exp19 | -1.85 |
| DABN 20μM R00 exp17 | -1.74 |
| Bortezomib 0.005μM R00 exp6 | 1.77 |
| CCCP 1μM R00 exp11 | 1.86 |
| Nocodazole 0.02μM R00 exp23 | 1.87 |
| Bisphenol F 50μM R08 exp457 | 2.24 |
| Thioridazine 5μM R08 exp530 | 2.32 |
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| TCEB3C | 0.545 |
| CEP192 | 0.544 |
| PSMB4 | 0.543 |
| TFIP11 | 0.541 |
| CDCA3 | 0.532 |
| VPS28 | 0.532 |
| GOLGA6L1 | 0.527 |
| CBWD3 | 0.526 |
| TCEB3CL | 0.526 |
| NSF | 0.524 |
| ATP6V1B2 | 0.522 |
| SAP30BP | 0.52 |
| AATF | 0.519 |
| CHD4 | 0.518 |
| TCEB3CL2 | 0.516 |
| COL2A1 | 0.514 |
| SUPT5H | 0.513 |
| RPL35 | 0.513 |
| RPS19BP1 | 0.513 |
| CBWD5 | 0.51 |
| TBC1D3F | 0.509 |
| CBWD6 | 0.508 |
| TBC1D3H | 0.507 |
| PRPF19 | 0.507 |
| NPIPB5 | 0.505 |
| TSPY8 | 0.504 |
| TWISTNB | 0.501 |
| TBC1D3G | 0.499 |
| NARFL | 0.499 |
| UTP3 | 0.497 |
| SNIP1 | 0.497 |
| TICRR | 0.496 |
| AAMP | 0.495 |
| ATP6V1C1 | 0.493 |
| PAN3 | 0.492 |
| XYLT2 | 0.49 |
| TP53TG3C | 0.488 |
| TP53TG3B | 0.488 |
| SLC4A1 | 0.488 |
| EXOSC9 | 0.488 |
| TP53TG3 | 0.488 |
| CHMP4B | 0.487 |
| OSBP | 0.487 |
| CHAF1A | 0.487 |
| POLR2J3 | 0.486 |
| PSMA6 | 0.486 |
| PLEKHA4 | 0.486 |
| LRR1 | 0.485 |
| PSMD7 | 0.484 |
| TBC1D3 | 0.484 |
| FAM231C | 0.484 |
| FAM231A | 0.484 |
| RPS12 | 0.483 |
| CDC45 | 0.482 |
| ORC1 | 0.482 |
| RRP7A | 0.481 |
| AKIRIN2 | 0.477 |
| PAF1 | 0.477 |
| VASN | 0.476 |
| KRT78 | 0.474 |
| DDTL | 0.473 |
| POLE | 0.472 |
| IGFN1 | 0.471 |
| PPFIA4 | 0.471 |
| WAPAL | 0.471 |
| TYMS | 0.471 |
| SLC6A17 | 0.471 |
| PSMB3 | 0.47 |
| C14orf93 | 0.47 |
| GAR1 | 0.469 |
| KCTD17 | 0.469 |
| C1QTNF9B | 0.469 |
| RPS7 | 0.469 |
| PAN2 | 0.468 |
| CCNA2 | 0.468 |
| RAD51 | 0.467 |
| ANKLE1 | 0.466 |
| CLN6 | 0.466 |
| PDCD7 | 0.466 |
| FCN2 | 0.465 |
| ORC6 | 0.464 |
| MT1E | 0.461 |
| WDR75 | 0.458 |
| AKT1S1 | 0.458 |
| ZFAND5 | 0.457 |
| NAALADL1 | 0.456 |
| ZNF830 | 0.455 |
| OR10G3 | 0.453 |
| ACSF2 | 0.453 |
| RRN3 | 0.451 |
| DOCK6 | 0.45 |
| TIMELESS | 0.45 |
| RANBP2 | 0.449 |
| ANKLE2 | 0.449 |
| NUPL1 | 0.449 |
| RNPC3 | 0.448 |
| CTAGE4 | 0.447 |
| TP53TG3D | 0.446 |
| EXOSC3 | 0.446 |
| PSMC2 | 0.445 |
| NOL10 | 0.445 |
| SNRPF | 0.445 |
| PCF11 | 0.444 |
| DNTTIP2 | 0.444 |
| DISP2 | 0.444 |
| RAD21 | 0.443 |
| AQR | 0.443 |
| CDT1 | 0.443 |
| ATP6V0B | 0.441 |
| EXOSC6 | 0.44 |
| CACTIN | 0.44 |
| PSMB2 | 0.439 |
| RPL7L1 | 0.439 |
| SMG7 | 0.438 |
| POLR2D | 0.438 |
| UPF1 | 0.438 |
| PNO1 | 0.438 |
| NUP153 | 0.436 |
| ATP6V0C | 0.435 |
| RPS19 | 0.435 |
| ATP6AP2 | 0.435 |
| ATP6V1A | 0.434 |
| DTL | 0.434 |
| SUPT6H | 0.434 |
| POLA2 | 0.433 |
| POLR2A | 0.432 |
| GOLGA8O | 0.431 |
| RBM8A | 0.43 |
| TINF2 | 0.429 |
| BYSL | 0.429 |
| CDH24 | 0.428 |
| SNRNP70 | 0.427 |
| SNRPA1 | 0.426 |
| HIST2H3A | 0.425 |
| CDC6 | 0.425 |
| POLR1A | 0.425 |
| DHX38 | 0.425 |
| HIST2H3C | 0.425 |
| COPG1 | 0.424 |
| MDN1 | 0.424 |
| PARP3 | 0.423 |
| LAD1 | 0.423 |
| WDR43 | 0.423 |
| RPS2 | 0.423 |
| SF3A1 | 0.422 |
| TBC1D3C | 0.422 |
| ADRM1 | 0.422 |
| EXOSC8 | 0.421 |
| HIVEP3 | 0.421 |
| SMG1 | 0.42 |
| MBTD1 | 0.419 |
| EIF4A3 | 0.419 |
| NOC4L | 0.419 |
| RPS9 | 0.418 |
| RBM39 | 0.417 |
| RPLP1 | 0.417 |
| MTCH2 | 0.417 |
| COPB1 | 0.417 |
| PPIE | 0.417 |
| UBL5 | 0.415 |
| FBXW9 | 0.415 |
| AURKA | 0.415 |
| NIPBL | 0.415 |
| INTS5 | 0.415 |
| PDCD11 | 0.415 |
| MYO1H | 0.415 |
| GID4 | 0.415 |
| GOLGA6A | 0.415 |
| C2orf27B | 0.414 |
| CDCA5 | 0.414 |
| CDC73 | 0.413 |
| INTS1 | 0.413 |
| FAM25B | 0.413 |
| TUBA8 | 0.412 |
| FOXD4L2 | 0.411 |
| RFFL | 0.411 |
| GOLGA6L6 | 0.411 |
| RRP15 | 0.41 |
| SYT9 | 0.41 |
| RPL6 | 0.409 |
| RRS1 | 0.409 |
| GOLGA6L3 | 0.409 |
| CCDC94 | 0.409 |
| PSMC1 | 0.408 |
| CCDC116 | 0.408 |
| ATP6AP1 | 0.408 |
| ARCN1 | 0.407 |
| EXD1 | 0.406 |
| DDX56 | 0.406 |
| RPL14 | 0.405 |
| TBC1D3I | 0.405 |
| TBC1D3L | 0.405 |
| CCDC12 | 0.405 |
| TBC1D3E | 0.405 |
| TBC1D3K | 0.405 |
| SCGB1C1 | 0.404 |
| PSMD11 | 0.404 |
| SH3BP1 | 0.404 |
| CCDC64B | 0.404 |
| STIL | 0.404 |
| EGR2 | 0.403 |
| TERF1 | 0.403 |
| HIST1H2BE | 0.403 |
| CLEC11A | 0.402 |
| EXOSC5 | 0.402 |
| RRM2 | 0.401 |
| SF3A2 | 0.401 |
| PPM1D | 0.4 |
| FAM160A1 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 700/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 27/28 |
| blood | 27/28 |
| bone | 23/26 |
| breast | 28/33 |
| central nervous system | 51/56 |
| cervix | 4/4 |
| colorectal | 17/17 |
| esophagus | 12/13 |
| fibroblast | 1/1 |
| gastric | 16/16 |
| kidney | 18/21 |
| liver | 20/20 |
| lung | 71/75 |
| lymphocyte | 16/16 |
| ovary | 25/26 |
| pancreas | 24/24 |
| peripheral nervous system | 15/16 |
| plasma cell | 15/15 |
| prostate | 1/1 |
| skin | 22/24 |
| soft tissue | 9/9 |
| thyroid | 2/2 |
| upper aerodigestive | 21/22 |
| urinary tract | 27/29 |
| uterus | 5/5 |
Essentiality in NALM6
- Essentiality Rank: 1228
- Expression level (log2 read counts): 6.87
Expression Distribution
IK Expression in NALM6 Cells: 6.87